Inhibitory Effect of Ketoconazole on the Pharmacokinetics of a Multireceptor Tyrosine Kinase Inhibitor BMS-690514 in Healthy Participants: Assessing the Mechanism of the Interaction With Physiologically-Based Pharmacokinetic Simulations-Reference-Cited by-同舟云学术

Inhibitory Effect of Ketoconazole on the Pharmacokinetics of a Multireceptor Tyrosine Kinase Inhibitor BMS-690514 in Healthy Participants: Assessing the Mechanism of the Interaction With Physiologically-Based Pharmacokinetic Simulations

Published:2013-02 Issue:2 Volume:53 Page:217-227
ISSN:0091-2700
Container-title:The Journal of Clinical Pharmacology
language:en
Short-container-title:J Clin Pharmacol

Author:

Yang Zheng¹,Vakkalagadda Blisse¹,Shen Guoxiang¹,Ahlers Christoph M.¹,Has Teresa¹,Christopher Lisa J.¹,Kurland John F.¹,Roongta Vikram¹,Masson Eric¹,Zhang Steven¹

Affiliation:

1. Bristol-Bristol Squibb; Princeton, NJ; USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1177/0091270012439208/fullpdf

Reference30 articles.

1. Molecular and biological properties of vascular endothelial growth factor;Ferrara;J Mol Med,1999

2. ERBB receptors and cancer: the complexity of targeted inhibitors;Hynes;Nat Rev Cancer,2005

3. The role of VEGF and EGFR inhibition: implications for combining anti-VEGF and anti-EGFR agents;Tabernero;Mol Cancer Res,2007